Sotyktu (deucravacitinib) - BMS
Response to Li, "Comment on 'Impact of a Novel Electronic Monitor on Psoriasis Patient Adherence to Prescribed Dose Frequency and Amount'". (PubMed, J Am Acad Dermatol) - Sep 13, 2026 - No abstract available 
Journal • Dermatology • Immunology • Psoriasis
http://www.ncbi.nlm.nih.gov/pubmed/42731701
 
Brett R Shaffer; Noah Z Linfeld; Steven R Feldman
 
Sep 13, 2026
 
Prev Next